{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Framingham",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "62127",
      "recalling_firm": "Genzyme Corporation",
      "address_1": "31,45,49,51,55,74,76, & 80 New York Ave.",
      "address_2": "N/A",
      "postal_code": "01702-5733",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide Distribution - US (nationwide) and the country of S. Korea",
      "recall_number": "Z-1856-2012",
      "product_description": "seprafilm¿ Single Site ADHESION BARRIER  Re-order Number: 6641-01    Product Usage:  Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.",
      "product_quantity": "1285 units",
      "reason_for_recall": "Sterility of product may be compromised due to packaging defect",
      "recall_initiation_date": "20120613",
      "center_classification_date": "20120621",
      "termination_date": "20130724",
      "report_date": "20120627",
      "code_info": "Lot number:  11NP685 . Exp 2014- 11"
    }
  ]
}